These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 8905746)
1. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas. Kyritsis AP; Yung WK; Jaeckle KA; Bruner J; Gleason MJ; Ictech SE; Flowers A; Levin VA Neurosurgery; 1996 Nov; 39(5):921-6. PubMed ID: 8905746 [TBL] [Abstract][Full Text] [Related]
2. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children. Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250 [TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance. Levin VA; Prados MD J Clin Oncol; 1992 May; 10(5):766-71. PubMed ID: 1314890 [TBL] [Abstract][Full Text] [Related]
5. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas. Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486 [TBL] [Abstract][Full Text] [Related]
6. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors. Prados MD; Larson DA; Lamborn K; McDermott MW; Sneed PK; Wara WM; Chang SM; Mack EE; Krouwer HG; Chandler KL; Warnick RE; Davis RL; Rabbitt JE; Malec M; Levin VA; Gutin PH; Phillips TL; Wilson CB Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):57-63. PubMed ID: 9422558 [TBL] [Abstract][Full Text] [Related]
7. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110 [TBL] [Abstract][Full Text] [Related]
8. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233 [TBL] [Abstract][Full Text] [Related]
9. Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma. Walbert T; Gilbert MR; Groves MD; Puduvalli VK; Yung WK; Conrad CA; Bobustuc GC; Colman H; Hsu SH; Bekele BN; Qiao W; Levin VA J Neurooncol; 2011 Apr; 102(2):273-80. PubMed ID: 20652724 [TBL] [Abstract][Full Text] [Related]
10. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Levin VA; Edwards MS; Wright DC; Seager ML; Schimberg TP; Townsend JJ; Wilson CB Cancer Treat Rep; 1980; 64(2-3):237-44. PubMed ID: 7407756 [TBL] [Abstract][Full Text] [Related]
11. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418 [TBL] [Abstract][Full Text] [Related]
12. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma. Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391 [TBL] [Abstract][Full Text] [Related]
13. Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas. Jakacki RI; Jamison C; Mathews VP; Heilman DK; Dropcho E; Cornetta K; Macdonald DR; Williams DA Med Pediatr Oncol; 1998 Dec; 31(6):483-90. PubMed ID: 9835900 [TBL] [Abstract][Full Text] [Related]
14. Tolerance of nitrosurea-based multiagent chemotherapy regime for low-grade pediatric gliomas. Lancaster DL; Hoddes JA; Michalski A J Neurooncol; 2003 Jul; 63(3):289-94. PubMed ID: 12892235 [TBL] [Abstract][Full Text] [Related]
16. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Rostomily RC; Spence AM; Duong D; McCormick K; Bland M; Berger MS Neurosurgery; 1994 Sep; 35(3):378-88; discussion 388. PubMed ID: 7800129 [TBL] [Abstract][Full Text] [Related]
17. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642 [TBL] [Abstract][Full Text] [Related]
18. Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study. Brandes AA; Ermani M; Turazzi S; Scelzi E; Berti F; Amistà P; Rotilio A; Licata C; Fiorentino MV J Clin Oncol; 1999 Feb; 17(2):645-50. PubMed ID: 10080610 [TBL] [Abstract][Full Text] [Related]
19. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study. Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438 [TBL] [Abstract][Full Text] [Related]
20. Bevacizumab is active as a single agent against recurrent malignant gliomas. Agha CA; Ibrahim S; Hassan A; Elias DA; Fathallah-Shaykh HM Anticancer Res; 2010 Feb; 30(2):609-11. PubMed ID: 20332478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]